Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release

Eur J Pharmacol. 1988 Mar 29;148(2):261-7. doi: 10.1016/0014-2999(88)90572-9.

Abstract

The tritium overflow evoked by electrical stimulation of rabbit hippocampal slices labeled with [3H]noradrenaline was inhibited by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel (N-VSCC). The magnitude of this inhibition was unchanged in the presence of substances which interact with N- and/or L-VSCCs (cadmium, neomycin, (-)- and (+)-202-791), alpha 2-adrenoceptors (idazoxan, UK-14304), protein kinase C (4 beta-phorbol-12,13-dibutyrate) or potassium channels (4-aminopyridine). This finding suggests that the attenuation of calcium-dependent neurotransmitter release by omega-conotoxin GVIA is relatively insensitive to alterations of such release effected by other substances.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminopyridines / pharmacology
  • Animals
  • Brimonidine Tartrate
  • Cadmium / pharmacology
  • Calcium Channel Blockers / pharmacology*
  • Dioxanes / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Idazoxan
  • In Vitro Techniques
  • Mollusk Venoms / pharmacology*
  • Neomycin / pharmacology
  • Nicotinic Acids / pharmacology
  • Norepinephrine / metabolism*
  • Oxadiazoles*
  • Phorbol Esters / pharmacology
  • Quinoxalines / pharmacology
  • Rabbits
  • omega-Conotoxin GVIA

Substances

  • Aminopyridines
  • Calcium Channel Blockers
  • Dioxanes
  • Mollusk Venoms
  • Nicotinic Acids
  • Oxadiazoles
  • Phorbol Esters
  • Quinoxalines
  • Cadmium
  • PN 202-791
  • Brimonidine Tartrate
  • omega-Conotoxin GVIA
  • Neomycin
  • Norepinephrine
  • Idazoxan